Prostate Cancer
Genetics may explain why calcium increases risk for prostate cancer
September 19, 2011
Prostate cancer can be detected even in patients with decreased PSA less than 2.5 ng/ml after treatment of chronic prostatitis - Abstract
September 16, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract
September 16, 2011
Clinical trial update and novel therapeutic approaches for metastatic prostate cancer - Abstract
September 16, 2011
The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy - Abstract
September 16, 2011
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy - Abstract
September 16, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer - Abstract
September 15, 2011
Construct validity in a high-fidelity prostate exam simulator - Abstract
September 15, 2011
Role of pelvic lymph node dissection in prostate cancer treatment - Abstract
September 15, 2011
Prostate-specific antigen testing across the spectrum of prostate cancer - Abstract
September 15, 2011
Active-targeted nanotherapy strategies for prostate cancer - Abstract
September 15, 2011
Transrectal implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT - Abstract
September 14, 2011